Regenerative Ophthalmology explores approaches aimed at repairing, replacing, or restoring damaged ocular tissues and visual function. The session brings together stem-cell research, tissue engineering, biomaterials, cell replacement, corneal and retinal regeneration, scaffold technologies, and emerging regenerative strategies with potential clinical applications.
Abstract Scope and Participation
Abstracts may address stem cells, tissue engineering, cell therapy, biomaterials, regenerative mechanisms, preclinical research, translational studies, and clinical applications. Ophthalmologists, cell biologists, biomedical researchers, engineers, translational scientists, and professionals developing regenerative technologies are encouraged to contribute.







Title : Lenadogene nolparvovec gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : Stereotactic radiotherapy for wet age-related macular degeneration: year 4 results of a randomised, double-masked, sham-controlled trial
Tim Jackson, King’s College London, United Kingdom